Report forecast the global cancer
supportive care market to grow at a CAGR of 3.38% during the period 2017-2021.
Cancer supportive care drugs are used for
the treatment of adverse effects caused due to the cancer treatment such as
chemotherapy-induced anemia, CINV, bone metastasis, cancer pain, and others.
Various class of drugs are used as cancer supportive care drugs. Some of the
major drug class that involves in cancer supportive care are antiemetic drugs,
erythropoietin-stimulating agents, granulocyte-stimulating agents, analgesics,
and others.
The report covers the present scenario and
the growth prospects of the global cancer supportive care market for 2017-2021.
To calculate the market size, the report considers sales of branded, generic,
and off-label drugs in cancer supportive care market.
The
market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
According to the report, one driver in the
market is large number of side effects associated with the cancer treatment.
Progress in cancer treatment has come with several challenges that go beyond a
cure. Morbidity and toxicities are among the few of the biggest hurdles faced
by cancer patients while going through radiation therapy or chemotherapy. A large
number of side effects are associated with the treatment of cancer. These have
been a major challenge for the traditional cancer treatment market (radiation
and chemotherapy). The main aim of cancer treatment is to get rid of the cancer
cells.
Further, the report states that one
challenge in the market is rising popularity of targeted therapies for the
treatment of cancer in developed countries. The increasing preference of
targeted therapies instead of chemotherapy drugs will hinder the growth prospects
in the market. As there is an increased need to target-specific molecules that
are responsible for the growth of cancer, the vendors are focusing on the
development of targeted therapies, which are highly specific than the
traditional chemotherapy drugs. Also, as chemotherapy drugs are associated with
higher side effects, the researchers are extensively conducting R&D
activities to understand the disease etiology better and develop novel
treatments.
Global
Cancer Supportive Care Market 2017-2021, has been
prepared based on an in-depth market analysis with inputs from industry
experts. The report covers the market landscape and its growth prospects over
the coming years. The report also includes a discussion of the key vendors
operating in this market.
key players in the global cancer supportive
care market: Amgen, Helsinn Healthcare, Johnson &Johnson, and Merck.
Other Prominent Vendors in the market are:
F. Hoffmann-La Roche, GlaxoSmithKline, Heron Therapeutics, Kyowa Hakko Kirin,
Novartis, TESARO, and Teva Pharmaceutical Industries.
Market
driver
- Large number of side effects associated with the cancer treatment
- For a full, detailed list, view our report
Market
challenge
- Rising popularity of targeted therapies for the treatment of cancer in developed countries
- For a full, detailed list, view our report
Market
trend
- Advent of biosimilars in cancer-associated treatment
- For a full, detailed list, view our report
Key
questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
Spanning over 96 pages “Global
Cancer Supportive Care Market 2017 - 2021” report covers Executive
summary, Introduction, Scope of the report, Research Methodology, Market
landscape, Pipeline landscape, Market segmentation therapeutic area,
Geographical segmentation, Decision framework, Drivers and challenges, Market
trends, Vendor landscape, Key vendor analysis, Appendix.
Please visit this link for more details: http://mrr.cm/UwH
For related reports please visit: Cancer Supportive Care Market Research Reports
Find all Pharma
and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.